Top 5 Google Startup Investors in Europe in May 2026

DN Capital is an early-stage venture capital firm that invests primarily in Europe and North America. The firm focuses on companies that plan to establish operations on both sides of the Atlantic, and strives to help its companies build international businesses. Founded in 2000, the company has operations in London and Silicon Valley. DN Capital’sprevious funds are top performers and the firm is one of the lead investors in companies such as Endeca (sold to Oracle), Shazam (one of the world’s leading mobile app), Auto1 (world's largest used car marketplace), Purplebricks (IPO London) and Quandoo (sold to Recruit).

Investment focus

Software, SaaS, E-Commerce
Series A, Series B, Seed
United States, Germany, United Kingdom

Portfolio highlights

Quandoo — In 8 years, Quandoo has expanded into 11 countries and has seated more than 200 million diners in 18,000+ restaurants. Quandoo’s technology-enabled marketplace equips both restaurants and diners with innovative products to elevate dining out as we know it. Headquartered in Berlin, with international footprints in Austria, Switzerland, Italy,Turkey, the UK, Hong Kong, Finland, Singapore, Australia and the Netherlands; the founders’ vision is to grow Quandoo into the world’s leading marketplace for dining out experiences. Quandoo is a subsidiary of Recruit Holdings, and with its sister companies HotPepper and AirRegi, forms the world’s largest restaurant marketing and software company. Quandoo currently employs more than 370 people from 50 countries.
Remitly — Send money online faster and more securely with Remitly, and discover our great exchange rates and low money transfer fees.
GoStudent — GoStudent is a platform for online teaching and is the future of tutoring. The EdTech company was founded in Vienna in 2016 by Felix Ohswald (CEO) and Gregor Müller (COO). Currently, GoStudent is operational in 15 markets. Via its platform, GoStudent provides paid, one-to-one, video-based tuition to primary, secondary, and college-aged students in20+ subjects, using a membership model. Lessons are booked via the GoStudent platform and accessed using a computer or a mobile device. During each tutoring session, students and tutors interact live in a virtual classroom. Integrated features, such as a whiteboard and the option to share a screen and edit documents together, are included. The cornerstone of this concept was laid in 2015 by Felix Ohswald and Gregor Müller when they established a WhatsApp-based homework chat service for students. GoStudent employs more than 600 people and has opened 12 international offices. Over 400,000 tutoring units are booked each month. Currently, GoStudent has around 15,000 customers and works with 5,500 international tutors. To date, GoStudent has raised more than €291m. Investors include Left Lane Capital, DN Capital, Coatue, and DST Global.

Show all investments...

We back early-stage B2B SaaS founders in the Nordics & Baltics with capital, expertise, and long-term partnership. See how we invest and support growth.

Investment focus

SaaS, Software, Analytics
Seed, Series A, Funding Round
Finland, United States, Canada

Portfolio highlights

Cluby — Cluby is a technology platform that provides restaurants with the best tools for managing and communicating with loyal consumers.
Claimlane — Claimlane is an end-to-end returns management solution for brands and retailers to manage any type of return, across all sales channels and markets. Perfectly document claims and returns. Streamline workflows. Get quality insights. Turn unhappy claimers into loyal customers. That's Claimlane.
Eyeball — Eyeball operates as a digital platform for youth football.

Show all investments...

We partner with deep tech and brand-driven companies obsessed in challenging category norms. The Nordics are our home, but we take on a global front in spotting the unexpected - from B2B to B2C, with a sweet spot for scientific advances, strong IP, and customer understanding that looks beyond convention.We invest in early stage companies: fromtheir inception to series A and beyond. We share in the vision of founders as champions and challengers, drawing on our experiences from scaling some of the strongest tech companies ourselves.

Investment focus

Software, E-Commerce, Information Technology
Seed, Series A, Funding Round
Finland, Norway, Denmark

Portfolio highlights

Disior — At Disior, we build software to measure and model tissue structures in CT- and MRI-images for better diagnosis and treatment planning.Our solutions are for clinical use. They enable fast, accurate and reproducible measuring for diagnostics and patient-specific, optimized treatment planning. Based on mathematical modelling, Disior algorithmsextract the correct shape or structure from the medical image. This way, the software is not dependent on finding familiar structures or comparing something to reference data. We combine engineering and R&D talent with medical and biotechnology professionals. Our team brings together decades of experience in creating world’s best simulation and modelling systems from smartphone R&D; clinicians and researchers in maxillofacial and orthopedics; and technology innovation and commercialization.For demo, pilots and research projects, please contact Anna-Maria Henell, CEO: +358 50 483 6433 / anna-maria (at) disior.com
Sera — Sera's AI streamlines prospecting with tailored lists and enriched profiles, including accurate emails and metrics.
IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.

Show all investments...

SVB - Europe's biggest online shop for boating equipment and accessories! Worldwide delivery, even directly on-board!

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Seed
The Netherlands, United States, Germany

Portfolio highlights

Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
NMD Pharma — NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise.Importantly, the approach improves neuromuscular transmission in a way that ispotentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.
TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.

Show all investments...